{"id":152407,"date":"2023-08-10T08:20:55","date_gmt":"2023-08-10T12:20:55","guid":{"rendered":"https:\/\/44.250.171.167\/?p=152407"},"modified":"2023-08-10T08:20:56","modified_gmt":"2023-08-10T12:20:56","slug":"shilpa-medicare-ltd-q1fy24-50-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q1fy24-50-fall-in-profits\/","title":{"rendered":"Shilpa Medicare Ltd Q1FY24; 50% fall in Profits"},"content":{"rendered":"\n<p>Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. SML is one of the worlds leading suppliers of Oncology\/ Non Oncology API&#8217;s and intermediates.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\">Financial Results:<\/h2>\n\n\n\n<p>Shilpa Medicare Ltd reported Revenues for Q1FY24 of \u20b9260.17 Crores down from \u20b9261.16 Crore year on year, a fall of 0.38%.<\/p>\n\n\n\n<p>Total Expenses for Q1FY24 of \u20b9258.81 Crores down from \u20b9273.33 Crores year on year, a fall of 5.31%.<\/p>\n\n\n\n<p>Consolidated Net Profit of \u20b91.18 Crores down 49.57% from \u20b92.34 Crores in the same quarter of the previous year.<\/p>\n\n\n\n<p>The Earnings per Share is \u20b90.14, up 40.00% from \u20b90.10 in the same quarter of the previous year.<\/p>\n\n\n\n<div class=\"wp-block-image\"><figure class=\"aligncenter size-large\"><a href=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png\"><img loading=\"lazy\" decoding=\"async\" width=\"839\" height=\"1024\" src=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579-839x1024.png\" alt=\"\" class=\"wp-image-152409\" srcset=\"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579-839x1024.png 839w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579-246x300.png 246w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579-768x937.png 768w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579-1259x1536.png 1259w, https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png 1489w\" sizes=\"auto, (max-width: 839px) 100vw, 839px\" \/><\/a><\/figure><\/div>\n\n\n\n<p>*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.<\/p>\n\n\n\n<p>*The presented data is automatically generated. It may occasionally generate incorrect information.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. SML is one of the worlds leading suppliers of Oncology\/ Non Oncology API&#8217;s and intermediates. Financial Results: Shilpa Medicare Ltd reported Revenues for Q1FY24 of \u20b9260.17 [&hellip;]<\/p>\n","protected":false},"author":1863,"featured_media":152409,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[10304,3187,1115],"class_list":["post-152407","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-api","tag-biotechnology","tag-pharmaceuticals"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-579.png","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":164607,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q1fy24-50-fall-in-profits-2\/","url_meta":{"origin":152407,"position":0},"title":"Shilpa Medicare Ltd Q1FY24; 50% fall in Profits","author":"Chirag Gupta","date":"October 1, 2024","format":false,"excerpt":"Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company\u2019s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML\u2019s wholly owned subsidiary Shilpa\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/10\/image-4.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":157236,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q2fy24-19-rise-in-revenue\/","url_meta":{"origin":152407,"position":1},"title":"Shilpa Medicare Ltd Q2FY24; 19% rise in Revenue","author":"Chirag Gupta","date":"December 11, 2023","format":false,"excerpt":"Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. SML is one of the worlds leading suppliers of Oncology\/ Non Oncology API's and intermediates. Financial Results: Shilpa Medicare Ltd reported\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/12\/image-74.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159746,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q3fy24-9-rise-in-revenue\/","url_meta":{"origin":152407,"position":2},"title":"Shilpa Medicare Ltd Q3FY24; 9% rise in Revenue","author":"Chirag Gupta","date":"March 12, 2024","format":false,"excerpt":"Shilpa Medicare is engaged in the business of high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. SML is one of the worlds leading suppliers of Oncology\/ Non Oncology API's and intermediates. Financial Results: Shilpa Medicare Ltd reported\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-116.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":161548,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-ltd-q4fy24-11-rise-in-revenue\/","url_meta":{"origin":152407,"position":3},"title":"Shilpa Medicare Ltd Q4FY24; 11% rise in Revenue","author":"Chirag Gupta","date":"May 23, 2024","format":false,"excerpt":"Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of its customers. The company\u2019s formulation products consist of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SML\u2019s wholly owned subsidiary Shilpa\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/05\/image-178.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":143005,"url":"https:\/\/alphastreet.com\/india\/shilpa-medicare-limited-q3fy23-earnings\/","url_meta":{"origin":152407,"position":4},"title":"Shilpa Medicare Limited Q3FY23 Earnings","author":"Karan_Singh","date":"February 28, 2023","format":false,"excerpt":"With cutting-edge technology, Shilpa Medicare is in the business of manufacturing high-quality Active Pharmaceutical Ingredients, Intermediates, Formulations, Novel Drug delivery system, Peptides, Biotechnology goods, and Specialty chemicals. SML is among the top providers of oncology- and non-oncology-related intermediates and APIs in the world. Financial Results - Management Commentary \"The company\u2026","rel":"","context":"In &quot;Earnings&quot;","block_context":{"text":"Earnings","link":"https:\/\/alphastreet.com\/india\/category\/earnings\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/tiny-pharmacist-with-pills-vitamins-flat-vector-illustration-doctors-writing-prescriptions-antibiotics-working-together-helping-patients-cure-pharmacy-business-drugstore-concept_74855-23225.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":154152,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q1fy24-49-fall-in-profits\/","url_meta":{"origin":152407,"position":5},"title":"Divi&#8217;s Laboratories Ltd Q1FY24; 49% fall in Profits","author":"Divyansh_Kasana","date":"August 16, 2023","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divi's Laboratories Ltd reported Revenues for Q1FY24 of \u20b91,778.00 Crores down from \u20b92,255.00 Crore year on year, a fall of 21.15%. Total Expenses for Q1FY24 of \u20b91,367.00 Crores down from \u20b91,491.00 Crores year on\u2026","rel":"","context":"In &quot;AlphaGraphs&quot;","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/152407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1863"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=152407"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/152407\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/152409"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=152407"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=152407"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=152407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}